Radiation InjuriesRadiation DosageRadiation, IonizingAntineoplastic AgentsRadiotherapyDose-Response Relationship, RadiationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyRadiotherapy DosageRadiation ToleranceRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiationRadiation OncologyNeoplasmsChemotherapy, AdjuvantRadiotherapy, AdjuvantRadiation ProtectionDose FractionationCisplatinRadiotherapy Planning, Computer-AssistedRadiation MonitoringCell Line, TumorTreatment OutcomeDoxorubicinRadiation PneumonitisBrachytherapyBreast NeoplasmsDrug Screening Assays, AntitumorNeoplasm Recurrence, LocalRadiation-Sensitizing AgentsNeoplasm StagingRadiosurgeryNeoplasms, Radiation-InducedRadiometryBrain NeoplasmsLung NeoplasmsDrug Resistance, NeoplasmSurvival AnalysisDisease-Free SurvivalProstatic NeoplasmsCranial IrradiationApoptosisHead and Neck NeoplasmsSurvival RateRadiotherapy, Computer-AssistedRadiation Injuries, ExperimentalGamma RaysAntineoplastic Agents, PhytogenicCell SurvivalPrognosisCarcinoma, Squamous CellEtoposideRadiotherapy, Image-GuidedPaclitaxelParticle AcceleratorsAdenocarcinomaMice, NudeFollow-Up StudiesTime FactorsCosmic RadiationRadiotherapy, High-EnergyAntibiotics, AntineoplasticXenograft Model Antitumor AssaysRadiodermatitisRetrospective StudiesChemoradiotherapyCyclophosphamideRadiation-Protective AgentsOrgans at RiskTumor BurdenCarcinoma, Non-Small-Cell LungDNA DamageTumor Cells, CulturedFluorouracilNeoplasm MetastasisTomography, X-Ray ComputedDrug Delivery SystemsVinblastineBackground RadiationAntimetabolites, AntineoplasticDose-Response Relationship, DrugDrug Administration ScheduleMastectomy, SegmentalNeoadjuvant TherapyCell ProliferationBleomycinClinical Trials as TopicDacarbazineCamptothecinCobalt RadioisotopesAntineoplastic Agents, AlkylatingUltraviolet RaysCarboplatinColonic NeoplasmsOvarian NeoplasmsRectal NeoplasmsPancreatic NeoplasmsCarcinomaGene Expression Regulation, Neoplastic